Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTCy-ATG vs ATG for Acute GVHD Prophylaxis in Haploidentical HSCT
NCT03689465Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide in graft-versus-host disease (GVHD), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
cyclophosphamide
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT03689465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689465.